Filter News
Area of Research
News Type
News Topics
- (-) Advanced Reactors (6)
- (-) Biomedical (11)
- (-) Energy Storage (9)
- (-) Fusion (10)
- (-) Isotopes (5)
- (-) Machine Learning (3)
- (-) Mercury (1)
- (-) Space Exploration (1)
- (-) Transformational Challenge Reactor (3)
- 3-D Printing/Advanced Manufacturing (17)
- Artificial Intelligence (6)
- Big Data (8)
- Bioenergy (6)
- Biology (3)
- Biotechnology (1)
- Chemical Sciences (4)
- Clean Water (2)
- Climate Change (3)
- Computer Science (23)
- Coronavirus (12)
- Cybersecurity (3)
- Environment (15)
- Exascale Computing (2)
- Grid (3)
- High-Performance Computing (2)
- Materials (2)
- Materials Science (17)
- Mathematics (2)
- Microscopy (3)
- Molten Salt (1)
- Nanotechnology (9)
- National Security (2)
- Neutron Science (14)
- Nuclear Energy (21)
- Physics (10)
- Polymers (2)
- Quantum Science (8)
- Security (2)
- Summit (7)
- Sustainable Energy (7)
- Transportation (7)
Media Contacts
![Brian Damiano](/sites/default/files/styles/list_page_thumbnail/public/2020-12/2016-P04442.jpg?h=49ab6177&itok=lPIC-H6L)
Brian Damiano, head of the Centrifuge Engineering and Fabrication Section, has been elected fellow of the American Society of Mechanical Engineers.
![Distinguished Inventors](/sites/default/files/styles/list_page_thumbnail/public/2020-12/inventors.jpg?h=4631f1c1&itok=xhAGY0kv)
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
![Porter Bailey started and will end his 33-year career at ORNL in the same building: 7920 of the Radiochemical Engineering Development Center.](/sites/default/files/styles/list_page_thumbnail/public/2021-01/2020-P17836.jpg?h=4cdfc2d0&itok=2rFoZlS6)
Porter Bailey started and will end his 33-year career at ORNL in the same building: 7920 of the Radiochemical Engineering Development Center.
![INFUSE logo](/sites/default/files/styles/list_page_thumbnail/public/2020-12/infuse_logo-011.jpg?h=f46fb64e&itok=Yrutrfll)
The INFUSE fusion program announced a second round of 2020 public-private partnership awards to accelerate fusion energy development.
![asset management](/sites/default/files/styles/list_page_thumbnail/public/2023-05/Picture9.png?h=cf4f3851&itok=rVU02eNT)
East Tennessee occupies a special place in nuclear history. In 1943, the world’s first continuously operating reactor began operating on land that would become ORNL.
![David Kropaczek](/sites/default/files/styles/list_page_thumbnail/public/2020-11/2016-P07859_0.jpg?h=49ab6177&itok=nsklImHq)
David Kropaczek, director of the Consortium for Advanced Simulation of Light Water Reactors, or CASL, at the Department of Energy’s Oak Ridge National Laboratory, has been named a fellow of the American Nuclear Society.
![Frontier supercomputer](/sites/default/files/styles/list_page_thumbnail/public/2023-01/frontier_0.jpg?h=a1e1a043&itok=J3IM_Xeh)
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
![Chuck Kessel](/sites/default/files/styles/list_page_thumbnail/public/2020-11/ChuckKesselProfile_0.jpg?h=8f9cfe54&itok=pTBVa7QK)
Chuck Kessel was still in high school when he saw a scientist hold up a tiny vial of water and say, “This could fuel a house for a whole year.”
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.